A repost from our colleagues in the Division of Molecular and Cellular Biosciences (MCB).
The National Science Foundation’s Directorate for Biological Sciences (BIO) is renewing its collaboration with the UK Research and Innovation (UKRI) Biotechnology and Biological Sciences Research Council (BBSRC), described in Dear Colleague Letter (DCL) NSF 20-118.
Titled “UKRI/BBSRC-NSF/BIO Lead Agency Opportunity in Biological Informatics, Microbes and the Host Immune System, Quantum Biology and Synthetic Cell,” the DCL describes four new topical areas associated with the lead agency opportunity. The lead agency scheme allows for reciprocal acceptance of peer review through unsolicited mechanisms and helps reduce some of the current barriers to international collaborations.
There is a two-part application process: a letter of Intention to Submit (due October 21, 2020) will be reviewed for project eligibility. Eligible proposals will then be invited to submit to the appropriate lead agency program. Refer to the DCL for important details.
Projects must be a collaboration between at least one investigator in the US and one in the UK, must address the priorities of both UKRI/BBSRC and appropriate NSF/BIO divisions, and must address the topical areas identified in the DCL. Additionally, proposers must provide a clear rationale for the need for a US-UK collaboration, including the unique expertise and synergy that the collaborating groups will bring to the project.
For full details on submission guidelines, program priorities, and contact information, see DCL NSF 20-118. Please also see this NSF announcement about the collaboration.